Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane and cell wall anionic components are essential structural and functional elements that provide a net negative charge to the bacterial surface, distinguishing them from the predominantly zwitterionic membranes of mammalian cells. In Gram-positive bacteria, these components include wall teichoic acids (WTA) and lipoteichoic acids (LTA), as well as acidic phospholipids like phosphatidylglycerol (PG) and cardiolipin (CL) (Swoboda et al., 2010, ChemBioChem). In Gram-negative bacteria, the primary anionic component is the lipopolysaccharide (LPS) in the outer membrane, specifically the phosphate groups on the lipid A moiety (Velkov et al., 2013, Journal of Medicinal Chemistry). These molecules are vital for maintaining cell wall integrity, regulating ion homeostasis, and protecting the cell from environmental stress (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). Because of their negative charge, these structures serve as the primary docking sites for cationic antimicrobial peptides (AMPs) and lipopeptides such as polymyxins and daptomycin (Zasloff, 2002, Nature). The interaction typically results in the disruption of the microbial membrane's physical integrity or the dissipation of the transmembrane potential, leading to rapid cell death (Muller et al., 2016, Biochimica et Biophysica Acta).
Cationic antimicrobial drugs utilize electrostatic attraction to bind to these anionic components, which is often followed by the insertion of hydrophobic regions into the lipid bilayer, leading to membrane thinning, pore formation, or 'carpet-like' disruption and subsequent depolarization (Brogden, 2005, Nature Reviews Microbiology; Zasloff, 2002, Nature). For specific agents like daptomycin, the interaction is calcium-dependent, where calcium ions bridge the drug to anionic phosphatidylglycerol to trigger membrane insertion (Humphries et al., 2011, Journal of Biological Chemistry).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and cell wall anionic components.